Suivant

Lecture automatique

Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia

7 Vues • 08/04/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evaluated nilotinib and chemotherapy for first-line treatment in elderly patients with de novo Philadelphia chromosome/BCR-ABL1-positive acute lymphoblastic leukaemia.

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique